Stockreport

Wegovy's Early Lead To Narrow As Eli Lilly Prepares Foundayo Launch [Seeking Alpha]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF The approval follows Novo Nordisk A/S's (NVO) launch of an oral version of Wegovy in January. Orforglipron is projected to generate about $1.6 billion in revenue in 2 [Read more]